Suppr超能文献

相似文献

2
Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.
Bioorg Med Chem. 2013 Dec 15;21(24):8019-32. doi: 10.1016/j.bmc.2013.08.035. Epub 2013 Sep 4.
4
Efficient Synthetic Methodology for the Construction of Dihydronaphthalene and Benzosuberene Molecular Frameworks.
Tetrahedron Lett. 2019 Jan 31;60(5):397-401. doi: 10.1016/j.tetlet.2018.12.033. Epub 2018 Dec 16.
6
Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Anticancer Agents Med Chem. 2018;18(4):556-564. doi: 10.2174/1871521409666170412115703.
10

引用本文的文献

2
Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin Polymerization.
ACS Med Chem Lett. 2025 May 26;16(6):1098-1107. doi: 10.1021/acsmedchemlett.5c00129. eCollection 2025 Jun 12.
4
Application of Chlorosulfonyl Isocyanate (CSI) in the Synthesis of Fused Tetracyclic Ketone Ring Systems.
J Org Chem. 2024 Nov 1;89(21):15636-15651. doi: 10.1021/acs.joc.4c01714. Epub 2024 Oct 10.
5
Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
Eur J Med Chem. 2024 Jan 5;263:115794. doi: 10.1016/j.ejmech.2023.115794. Epub 2023 Sep 6.
6
Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues.
Bioorg Med Chem. 2023 Sep 7;92:117400. doi: 10.1016/j.bmc.2023.117400. Epub 2023 Jun 29.
8
Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.
Medchemcomm. 2019 Jun 4;10(8):1445-1456. doi: 10.1039/c9md00127a. eCollection 2019 Aug 1.
9
Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research.
Tetrahedron Lett. 2018 Oct 3;59(40):3594-3599. doi: 10.1016/j.tetlet.2018.08.021. Epub 2018 Aug 14.
10
Efficient Synthetic Methodology for the Construction of Dihydronaphthalene and Benzosuberene Molecular Frameworks.
Tetrahedron Lett. 2019 Jan 31;60(5):397-401. doi: 10.1016/j.tetlet.2018.12.033. Epub 2018 Dec 16.

本文引用的文献

1
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
ACS Med Chem Lett. 2010 Jun 18;1(6):290-4. doi: 10.1021/ml1000855. eCollection 2010 Sep 9.
3
A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.
Integr Biol (Camb). 2011 Apr;3(4):375-87. doi: 10.1039/c0ib00135j. Epub 2011 Feb 14.
7
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P).
Expert Opin Investig Drugs. 2009 Feb;18(2):189-97. doi: 10.1517/13543780802691068.
10
Studies in tissue metabolism: The action of colchicine and B. typhosus extract.
Biochem J. 1937 Mar;31(3):454-60. doi: 10.1042/bj0310454.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验